Cargando…
Presence of Extra-Criteria Antiphospholipid Antibodies Is an Independent Risk Factor for Ischemic Stroke
Background: Ischemic stroke is the most common and severe arterial thrombotic event in Antiphospholipid syndrome (APS). APS is an autoimmune disease characterized by the presence of thrombosis and antiphospholipid antibodies (aPL), which provide a pro-coagulant state. The aPL included in the classif...
Autores principales: | Naranjo, Laura, Ostos, Fernando, Gil-Etayo, Francisco Javier, Hernández-Gallego, Jesús, Cabrera-Marante, Óscar, Pleguezuelo, Daniel Enrique, Díaz-Simón, Raquel, Cerro, Mercedes, Lora, David, Martínez-Salio, Antonio, Serrano, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126615/ https://www.ncbi.nlm.nih.gov/pubmed/34012984 http://dx.doi.org/10.3389/fcvm.2021.665741 |
Ejemplares similares
-
The Weight of IgA Anti-β2glycoprotein I in the Antiphospholipid Syndrome Pathogenesis: Closing the Gap of Seronegative Antiphospholipid Syndrome
por: Cabrera-Marante, Oscar, et al.
Publicado: (2020) -
Immune Complexes of Beta-2-Glycoprotein I and IgA Antiphospholipid Antibodies Identify Patients With Elevated Risk of Thrombosis and Early Mortality After Heart Transplantation
por: Serrano, Manuel, et al.
Publicado: (2019) -
Anti-Phospholipid Antibodies and COVID-19 Thrombosis: A Co-Star, Not a Supporting Actor
por: Gil-Etayo, Francisco Javier, et al.
Publicado: (2021) -
Effective Natural Killer Cell Degranulation Is an Essential Key in COVID-19 Evolution
por: Garcinuño, Sara, et al.
Publicado: (2022) -
T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression
por: Gil-Etayo, Francisco Javier, et al.
Publicado: (2021)